TB-500 10mg

TB-500 10mg Research Peptide

TB-500 10mg is a synthetic peptide material intended exclusively for laboratory, analytical, and scientific research applications.

FDA’s substance database identifies TB-500 as the N-terminal acetylated 17–23 fragment of thymosin beta-4, with the peptide sequence LKKTETQ. FDA also notes that assignment of a substance identifier does not represent regulatory review or approval.

TB-500 may be used in controlled research environments for studies such as:

• Peptide identity and characterization
• Analytical method development
• Peptide purity assessment
• Molecular and biochemical investigations
• Peptide stability research
• In-vitro experimental models
• Comparative peptide analysis
• Laboratory assay development

Product Information

• Product: TB-500
• Strength: 10mg
• Peptide Sequence: LKKTETQ
• Product Type: Synthetic research peptide
• Research Area: Peptide and biochemical research
• Intended Setting: Laboratory and scientific research
• Supplier: Peptides R US

Research Use Only

This material is offered exclusively for legitimate laboratory, analytical, and scientific research purposes.

It is not intended for human or veterinary use, consumption, administration, diagnosis, treatment, mitigation, cure, or prevention of any disease or medical condition.

No dosage, injection, administration, therapeutic-use, or human-use instructions are provided or implied.

For regulatory context, FDA currently states that compounded products containing the TB-500/thymosin beta-4 fragment may present immunogenicity and peptide-impurity concerns, and that FDA has not identified human-exposure data for drug products containing this fragment.